-
1
-
-
33846995945
-
Oral ganciclovir versus low-dose valganciclovir for prevention of cytomegalovirus disease in recipients of kidney and pancreas transplants
-
Weng FL, Patel AM, Wanchoo R, et al. Oral ganciclovir versus low-dose valganciclovir for prevention of cytomegalovirus disease in recipients of kidney and pancreas transplants. Transplantation 2007; 83: 290.
-
(2007)
Transplantation
, vol.83
, pp. 290
-
-
Weng, F.L.1
Patel, A.M.2
Wanchoo, R.3
-
2
-
-
20144385981
-
Cytomegalovirus prophylaxis with valganciclovir in African-American renal allograft recipients based on donor/recipient serostatus
-
Gruber SA, Garnick J, Morawski K, et al. Cytomegalovirus prophylaxis with valganciclovir in African-American renal allograft recipients based on donor/recipient serostatus. Clin Transplant 2005; 19: 273.
-
(2005)
Clin Transplant
, vol.19
, pp. 273
-
-
Gruber, S.A.1
Garnick, J.2
Morawski, K.3
-
3
-
-
4644339105
-
Efficacy and safety of low-dose valganciclovir for prevention of cytomegalovirus disease in renal transplant recipients: A single-center, retrospective analysis
-
Gabardi S, Magee CC, Baroletti SA, et al. Efficacy and safety of low-dose valganciclovir for prevention of cytomegalovirus disease in renal transplant recipients: A single-center, retrospective analysis. Pharmacotherapy 2004; 24: 1323.
-
(2004)
Pharmacotherapy
, vol.24
, pp. 1323
-
-
Gabardi, S.1
Magee, C.C.2
Baroletti, S.A.3
-
4
-
-
0037531594
-
Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis
-
Akalin E, Sehgal V, Ames S, et al. Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis. Am J Transplant 2003; 3: 731.
-
(2003)
Am J Transplant
, vol.3
, pp. 731
-
-
Akalin, E.1
Sehgal, V.2
Ames, S.3
-
5
-
-
18644362332
-
Cytomegalovirus prophylaxis using oral ganciclovir or valganciclovir in kidney and pancreas-kidney transplantation under antibody preconditioning
-
Keven K, Basu A, Tan HP, et al. Cytomegalovirus prophylaxis using oral ganciclovir or valganciclovir in kidney and pancreas-kidney transplantation under antibody preconditioning. Transplant Proc 2004; 36: 3107.
-
(2004)
Transplant Proc
, vol.36
, pp. 3107
-
-
Keven, K.1
Basu, A.2
Tan, H.P.3
-
6
-
-
1942469969
-
Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients
-
Paya C, Humar A, Dominguez E, et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2004; 4: 611.
-
(2004)
Am J Transplant
, vol.4
, pp. 611
-
-
Paya, C.1
Humar, A.2
Dominguez, E.3
-
7
-
-
0033807143
-
Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients
-
Pescovitz MD, Rabkin J, Merion RM, et al. Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients. Antimicrobial Agents Chemother 2000; 44: 2811.
-
(2000)
Antimicrobial Agents Chemother
, vol.44
, pp. 2811
-
-
Pescovitz, M.D.1
Rabkin, J.2
Merion, R.M.3
-
8
-
-
21144452373
-
Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipients
-
Wiltshire H, Hirankarn S, Farrell C, et al. Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipients. Clin Pharmacokinet 2005; 44: 495.
-
(2005)
Clin Pharmacokinet
, vol.44
, pp. 495
-
-
Wiltshire, H.1
Hirankarn, S.2
Farrell, C.3
-
9
-
-
0031581506
-
Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients
-
Letters to the Editor
-
Gane E, Saliba F, Valdecasas GJ, et al. Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. Lancet 1997; 350: 1729. Letters to the Editor
-
(1997)
Lancet
, vol.350
, pp. 1729
-
-
Gane, E.1
Saliba, F.2
Valdecasas, G.J.3
|